Year

2013

Status

Exited

 

Team

Field

Immuno-oncology therapeutic

Location

Oss (The Netherlands)

Fund

BGV II

Acerta Pharma

Acerta Pharma develops novel therapeutics in oncology and autoimmune diseases. In 2016 AstraZeneca acquired a majority stake in Acerta Pharma.